Wordt geladen...

Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research

Pancreatic ductal adenocarcinoma is an aggressive cancer with high recurrence rates following surgical resection. While adjuvant chemotherapy improves survival, a significant proportion of patients are unable to initiate or complete all intended therapy following pancreatectomy due to postoperative...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:World J Gastroenterol
Hoofdauteurs: Cloyd, Jordan M, Tsung, Allan, Hays, John, Wills, Celia E, Bridges, John FP
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Baishideng Publishing Group Inc 2020
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7002907/
https://ncbi.nlm.nih.gov/pubmed/32063686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i4.375
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!